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We have evaluated the DNA vaccination strategy for measles virus (MV) hemagglutinin (HA) and nucleoprotein (NP) genes.
Plasmids encoding either the MV, HA, or NP proteins inoculated intramuscularly into Balb/c mice induced both humoral
and CTL class I restricted responses. Antibody responses were not increased by multiple inoculations. The major antibody
isotype induced by both the HA and NP was IgG2a consistent with a Th1 response. In contrast, immunization with a plasmid
which directed the synthesis of a partially secreted form of HA gave mainly IgG1 antibodies. When the amount of DNA was
reduced for the HA plasmid (1 or 10 mg/animal), although the antibody was not induced, a CTL response was observed.
q 1996 Academic Press, Inc.
INTRODUCTION optimum protection. Furthermore, the response to the
individual antigens should be balanced so as to avoid
The attenuated measles vaccine has been used for
possible vaccination problems as observed with the
more than three decades with a high degree of success
formaldehyde-inactivated and high-titer vaccines (Fulgin-
in the West, but in the developing countries where mea-
iti et al., 1967). Future vaccines should have an optimal
sles infections occur at an earlier age, protection at these
antigen composition that also induces the correct Th1/
younger ages is difficult to achieve due to the presence
Th2 balance.
of maternal antibody. One of the measures taken to try
The observation that inoculation of plasmid DNA ex-
to overcome this problem has been to use a high-titer
pression vectors into the muscle of animals can induce
measles vaccine (Garenne et al., 1991). However, al-
an immune response to the encoded proteins showed
though this resulted in higher sero-conversion rates,
the potential of this technology in the field of vaccinology
long-term mortality actually increased. Such observa-
(for review see Donnelly et al., 1993). Using this system,
tions underline our present lack of understanding of the
individual viral proteins can be expressed and processed
immunobiology of measles infections.
in conditions similar to these of the natural infection.
To study which measles virus (MV) proteins contribute
As a first step to assessing its applicability to measles
to protection against infection, cloned MV genes have
vaccination, we have immunized mice with DNA encod-
been expressed using a number of vectors and the im-
ing the MV-HA and nucleoprotein (NP) genes and have
mune responses provoked by the individual proteins as-
studied the immune response. We show that for both
sessed. The two envelope glycoproteins, the hemaggluti-
viral proteins, humoral and cytotoxic T lymphocyte (CTL)
nin (HA) and fusion (F) proteins, both protect against
responses were induced.
infection (Drillien et al., 1988). Similar results have been
obtained after passive administration of monoclonal anti-
MATERIALS AND METHODSbodies (anti-HA or anti-F), suggesting that the humoral
response to these proteins contributes to protection (Gi-
Construction of vaccine DNAs
raudon and Wild, 1985; Malvoisin and Wild, 1990). In
contrast, fewer studies have examined the cell-mediated cDNAs encoding the MV-HA (Gerald et al., 1986) and
immune response, although it has been shown that T- MV-NP (Buckland et al., 1988) were subcloned into the
helper cells specific for several MV proteins protect rats BglII site of the plasmid pV1J (Montgomery et al., 1993),
against intracerebral challenge (Reich et al., 1992). which is driven by the CMV promoter. To facilitate these
In developing new vaccine strategies for measles, it constructions, site-directed mutagenesis (Kunkel, 1985)
will be necessary to determine which antigens give the was used to introduce BamHI sites at the 5* and 3* ends
of the MV-HA cDNA and BglII sites at the 5* and 3* ends
of the MV-NP cDNA. Furthermore, site-directed mutagen-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (33) 72 72 25 67. E-mail: fwipaly@imaginet.fr. esis was used to optimize the kozak sequences of the
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ATGs in both cDNAs in order to optimize the expression
of the encoded proteins (Kozak, 1986).
Cells
CTL assays were performed in P815 (H-2d) cells (which
express MHC class I but not class II molecules) and
derivatives of these cells expressing high levels of the
MV antigens H and NP (P815-H and P815-NP, respec-
tively) as described in Beauverger et al. (1993a). For
ELISA assays, Ltk0 and Ltk H- or NP-expressing cells
were used (Beauverger et al., 1993b).
Mice
BALB/c (H-2d) female mice were obtained from IFFA-
CREDO (France). Five- to 6-week-old mice were immu-
nized with 1 to 100 mg of DNA in 50 ml of PBS in the
quadricep muscles (im). The mice were boosted at 3-
week intervals.
Antibody assays FIG. 1. Anti-MV HA antibody response as measured by ELISA in
mice injected im with 100 mg of pV1J-HA. Sera were collected 3 weeksMV-neutralizing antibodies were measured using two-
after the last immunization. Data represent individual animals. Sera
fold dilutions of serum against 25 PFU of virus in 96-well from mice immunized with a control pV1J had a mean { SD value of
microtiter plates. Vero cells were used as indicator cells 127 { 360 anti-HA ELISA units (n  8).
as previously described (Wild and Huppert, 1980). Anti-
body responses to the MV-HA and MV-NP proteins were
were radiolabeled with 50 mCi 51Cr for 90 min at 377,measured by ELISA. Ltk0 cells constitutively expressing
washed twice in DMEM-1% FCS, incubated for 1 hr inthe HA or NP proteins (Beauverger et al., 1993b) were
DMEM-10% FCS, and washed once before using in a 4grown in 96-well microtiter plates. Antisera dilutions
hr 51Cr release assay. The percentage of cell lysis waswere incubated with the intact cells (for HA) or acetone
calculated as [(experimental c.p.m. 0 spontaneous(80%) fixed cells (for NP) for 90 min at 377. After the HA-
c.p.m.)/(total c.p.m.0 spontaneous release)] 1 100. Non-antibody step, the complexes were fixed with a mixture
specific percentage of lysis, obtained with P815 targetof acetone/water (80:20) for 10 min at0207C. The specific
cells was subtracted. Results are expressed as percent-antibody response was developed with biotinylated anti-
age of specific lysis. Spontaneous release and total re-mouse IgG1, IgG2a, or IgG(gchain) and the streptavidine-
lease were determined from target cells incubated withphosphatase alkaline system (Sigma, France). Results
medium alone or after the addition of 100 ml of 1 M HCl,are expressed with reference to control anti-HA or anti-
respectively. Normally the background was less thanNP antibodies which were used to standardize assays
10%, but in exceptional cases, individual mice had up tofor IgG1 and IgG2a. Titers were calculated using the
30% in 30/1 E/T ratio.SOFTmax programme (Molecular Device Corp., Menlo
Park, CA). Data are given as relative ELISA units.
RESULTS
Cytotoxic T-lymphocyte (CTL) assays
Immune response to MV-HA DNA
Spleens were removed from immunized animals and,
after elimination of red blood cells by perfusion with The cDNA for the MV-HA (Gerald et al., 1986) was
subcloned into the vector pV1-J. Transfected into murineDMEM, cocultivated with P815(H-2d) cells expressing the
corresponding MV protein (HA or NP) (Beauverger et al., L cells, this gave a high level of expression of HA as
measured by immunofluorescence (data not shown). To1993b), which had been incubated with mitomicin C (25
mg/ml) for 30 min at 377. The ratio of spleen to stimulator test the ability of pV1J-HA to induce an immune response,
Balb/c mice were inoculated im 1–3 times at 3-weekcells was 10:1. The cocultures (11 1 106 cells/well) were
distributed in 24-well plates and incubated in DMEM- intervals with 100 mg of plasmid and the antibody levels
measured by ELISA (Fig. 1). At the concentration of plas-10% FCS containing 5 1 1005 M-2-mercaptoethanol. On
Day 5, half the medium was changed and the cytotoxic mid used (100 mg/mouse), high levels of antibody were
obtained irrespective of the number of inoculations. Inactivity was tested on Day 7.
For the CTL assays P815, P815-H, or P815-NP cells a small number of cases, mice failed to seroconvert.
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Examination of the serum for MV neutralization showed
titers up to 320 after a single inoculation of 100 mg of
DNA (Table 1). Studies on the CTL activity of the immu-
nized mice confirmed the results obtained for the hu-
moral response, i.e., pV1J-HA induced good CTL re-
sponses even with a single inoculation (Fig. 2). When
P815-NP cells were used as negative control targets, no
cross-reactive lysis was observed, thus confirming the
antigen specificity of the CTLs. Furthermore, no NK activ-
ity could be detected in these effectors, since they could
not lyse the NK-sensitive YAC targets (data not shown).
Measurement of antibody levels up to 8 12 months after
immunization showed the antibody levels to be main-
tained throughout this period (Fig. 3).
In contrast to the results obtained after inoculating 100
mg of pV1J-HA, when lower doses were used (1, 10, or
50 mg/dose/mouse), even after three inoculations we
failed to detect anti-HA antibodies. However, CTL activity
was observed in the majority of cases (Fig. 4).
Targeting MV-HA to other tissues
To investigate if it would be advantageous to target
antigens to other cells for immune responses, since mus-
cle cells are not considered as antigen presenting cells,
an HA protein was engineered in which the first ATG was
in the middle of the transmembrane region. Transfection
studies in vitro using this plasmid (pV1J-sol-HA) estab-
lished that 10% of the total HA protein synthesized was
excreted into the medium (data not shown).
Balb/c mice were immunized im with either the stan-
dard or pV1J-sol-HA plasmids and the antibody (Fig. 5)
and CTL (Fig. 6) responses examined. Although the over-
all humoral and CTL responses were similar for the two
HA molecules, there was a switch in the antibody isotype
produced. The standard HA induced mainly an IgG2a
response which is indicative of a Th1-type response,
TABLE 1
Induction of Measles Virus Neutralizing Antibodies
after Intramuscular Inoculation of pV1J-HA
FIG. 2. Anti-MV HA CTL response after immunization with pV1J-HA.Plasmid Mouse Neutralizing titer
Balb/c mice were injected im with 100 mg of pV1J-HA once (a), twice (b),
or three times (c) at 3-week intervals. The spleen cells were removed 3pV1J-HA 1 20
weeks after the last immunization. After in vitro stimulation with P815-2 320
HA cells lysis was measured on P815-HA and P815 (control) cells. The3 160
results show the specific lysis of individual mice at graded E/T ratios.4 20
5 80
pV1J-sol-HA 6 20
7 20 whereas the sol-HA induced IgG1 which is associated
8 20 with a Th2 response.
9 20
10 20
Immune response to MV-NP DNA
Note. Balb/c mice were immunized im with 100 mg of pV1J-HA DNA
The cDNA for MV-NP (Buckland et al., 1988) was sub-and the MV serum neutralizing antibodies were measured 4 weeks
later. cloned into the pV1J plasmid and after transfection of
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murine L cells was shown to give a high level of expres-
sion of the MV protein (data not shown). To study the
immune response, Balb/c mice were inoculated im 1– 3
times with 100 mg of pV1J-NP. Similar to the HA study,
a good humoral response was obtained after a single
immunization (Fig. 7) and the antibody isotype produced
was predominantly of the IgG2a class (Fig. 8). A strong
CTL response was also obtained (Fig. 9). When P815-H
cells were used as negative control target, no cross-
reactive lysis was observed, thus confirming the antigen
specificity of the CTLs. Furthermore, no NK activity could
be detected in these effectors, since they could not lyse
the NK-sensitive YAC targets (data not shown).
DISCUSSION
Natural infection by measles gives life-long immunity.
The attenuated virus vaccine has now been used for
three decades and although the antibody titers induced
are lower than in natural infections, specific MV antibody
has been detected more than 20 years after vaccination
FIG. 4. Anti-MV HA CTL response in Balb/c mice injected im with 1
(a), 10 (b), or 50 mg (c) pV1J-HA. The spleens were removed 3 weeks
after immunization. After in vitro stimulation with P815-HA cells lysis
was measured on P815-HA and P815 (control) cells. Each curve shows
the specific lysis of individual mice at graded E/T ratios.
(Miller, 1987). In the developing countries, children be-
come infected at an earlier age, but the persisting level of
maternal antibody reduces the efficiency of the vaccine.
There is therefore, a need for a vaccine which can be
FIG. 3. Persistence of anti-MV HA antibodies after immunization with used early in life and if it is a vectored vaccine, maternal
pV1J-HA. Balb/c mice were injected im with 100 mg pV1J-HA once (n),
antibodies to the vector should be absent. If DNA vac-twice (L), or three times (s) at 3-week intervals. The antibody response
cines can express antigen over a period of time as haswas measured by ELISA and the results are expressed for individual
mice. been reported for a construct encoding a reporter gene
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FIG. 5. Isotype of antibodies induced after immunization (im) with
the standard pV1J-HA or a secreted version (pV1J-sol-HA). Balb/c mice
were injected twice (100 mg DNA) at an interval of 3 weeks. Data
represent individual animals. Sera from mice immunized with a control
pV1J had mean { SD values of 94 { 220 (n  10) and 192 { 441 (n
 11) anti-HA ELISA units for IgG1 and IgG2a, respectively.
(Wolff et al., 1990), a DNA vaccine may offer utility in
infants who still have maternal antibodies to measles.
Additionally, in view of this, we have examined the possi-
FIG. 7. Anti-MV NP antibody response as measured by ELISA in
Balb/c mice injected im with 100 mg of pV1J-NP. Sera were collected
3 weeks after the last immunization. Data represent individual animals.
Sera from mice immunized with a control pV1J had a mean { SD value
of 196 { 237 anti-NP ELISA units (n  8).
bility of DNA vaccination as a means of inducing a bal-
anced immune response.
Protection against measles infection is observed after
the passive transfer of g-globulin to children. The speci-
ficity of this protection has been confirmed using anti-
MV-HA and anti-MV-F monoclonal antibodies in a mouse
model (Giraudon and Wild, 1985; Malvoisin and Wild,
1990). In contrast although there is no direct evidence
for the involvement of cell-mediated immunity, children
with T-cell deficiencies suffer complications in measles
infections (Burnett, 1968). More recently, using a murine
model we have shown that despite the inability of MV-
specific CTLs to block infection, mice were protected
from a lethal challenge (Beauverger et al., 1996).
In the present study, MV genes expressed from a cyto-
megalovirus promoter in the plasmid pV1J induced both
humoral and CTL responses. The HA and NP were cho-
sen as previous studies established that immunization
of Balb/c mice with vaccinia recombinants expressing
these proteins induced both humoral and CTL immunity.
Intramuscular inoculation of 100 mg of DNA of either
pV1J-HA or pV1J-NP induced both humoral and CTL re-
sponses. The magnitude of the response was not in-
FIG. 6. Anti-MV HA CTL response in Balb/c mice immunized with
creased by multiple inoculations when given during a 6-pV1J-HA (a) or a secreted version (pV1J-sol-HA) (b). Immunization as
week period and there was no correlation between CTLdescribed in the legend of Fig. 5. The results show the specific lysis
of individual mice at graded E/T ratios. and antibody level for individual animals. Even after a
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single inoculation, both humoral and CTL responses
could be detected more than 8 months later. In contrast,
when lower quantities of DNA were inoculated (1 or 10
mg) only CTL responses could be detected.
In murine models, the antibody isotype induced is pre-
dominantly IgG2a with a 10- to 100-fold excess over IgG1
(Coutelier et al., 1987). Compared to IgG1, IgG2a has the
advantage that it can activate both the classical and the
alternative pathways of complement fixation (Klaus et al.,
1979). It has been postulated that the antibody isotype
is a reflection on the Th1/Th2 response. Interferon-g
which is associated with the Th1 cells has been shown
to upregulate IgG2a production (Snapper and Paul, 1987).
In contrast, IgG1 synthesis has been associated with
Th2 cells (Mosmann and Coffmann, 1989). Intramuscular
immunization with either HA or NP DNA induced IgG2a.
A number of hypotheses have been forwarded to ex-
plain the mechanism of the immune response following
im inoculation. One possibility is that the antigen is re-
leased from the muscle cells and captured by antigen-
presenting cells. To investigate this, we used a DNA
which encodes an HA which is partially secreted from
cells. The antibodies induced by this mixture of secreted
and membrane bound proteins were of the IgG1 isotype
and typical of a Th2 response. This would suggest that
when at least a portion of the antigen is released from
the cell, the antigen presentation may differ sufficiently
to alter the type of immune response. The present study
shows that intramuscular immunization with MV DNA
FIG. 9. Anti-MV NP CTL response in Balb/c mice injected im with
100 mg of pV1J-HA either once (a) or three times (b). The spleen cells
were taken 9 weeks (1 inoculation) or 3 weeks (3 inoculations) after
the last inoculation. After in vitro stimulation with P815-NP cells, lysis
was measured on P815-NP and P815 (control) cells. The results show
the specific lysis of individual mice at graded E/T ratios.
induces an immune response fulfilling certain criteria
required by a potential vaccine.
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